Lv2
170 积分 2024-09-05 加入
Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2
23天前
已完结
Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism
26天前
已完结
Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes
26天前
已完结
The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT study
26天前
已完结
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial
26天前
已完结
Safety Outcomes of Apixaban Compared With Warfarin in Patients With End-Stage Renal Disease
26天前
已完结
Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis
26天前
已完结
Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease
26天前
已完结
Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding
26天前
已完结
The Safety of Direct Oral Anticoagulants Versus Warfarin Among Older Individuals With Acute Venous Thromboembolism and CKD: A Population-Based Cohort Study
26天前
已完结
皖公网安备34019202002308
